Madrigal Pharmaceuticals (MDGL) Current Leases (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) posted quarterly Current Leases of $1.0 million for Q2 2026, down 1.43% year-over-year from $1.0 million in Q2 2025, and down 39.07% quarter-over-quarter from $1.7 million in Q1 2026.
Madrigal Pharmaceuticals (MDGL) Current Leases (2010 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has reported Current Leases for 15 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Current Leases fell 1.43% year-over-year to $1.0 million; the TTM figure through Jun 2026 stood at $1.0 million (down 1.43% YoY), while the FY2025 annual figure was $1.0 million, up 3.56% from the prior year.
- Current Leases declined to $1.0 million in Q2 2026 per MDGL's latest filing, from $1.7 million in the prior quarter.
- Across five years, Current Leases topped out at $1.7 million in Q1 2026 and bottomed at $411000.0 in Q2 2023.
- Historically, Current Leases has averaged $811944.4 across 5 years, with a median of $819000.0 in 2022.
- Annual changes were most pronounced in 2022 — Current Leases surged 118.11% — and 2023, when it slumped 53.24%.
- Madrigal Pharmaceuticals' Current Leases stood at $602000.0 in 2022, then retreated by 12.46% to $527000.0 in 2023, then jumped by 86.53% to $983000.0 in 2024, then rose by 3.56% to $1.0 million in 2025, then advanced by 1.57% to $1.0 million in 2026.
- Business Quant data shows MDGL's Current Leases at $1.0 million in Q2 2026, $1.7 million in Q1 2026, and $1.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Madrigal Pharmaceuticals | 14.79 Bn | 13.95 Bn | - | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.03 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | 1.02 Mn |
| Dec 31, 2024 | 983,000.00 |
| Sep 30, 2024 | 878,000.00 |
| Jun 30, 2024 | 557,000.00 |
| Mar 31, 2024 | 542,000.00 |
| Dec 31, 2023 | 527,000.00 |
| Sep 30, 2023 | 513,000.00 |
| Jun 30, 2023 | 411,000.00 |
| Mar 31, 2023 | 653,000.00 |
| Dec 31, 2022 | 602,000.00 |
| Sep 30, 2022 | 760,000.00 |
| Jun 30, 2022 | 879,000.00 |
| Mar 31, 2022 | 413,000.00 |
| Dec 31, 2021 | 410,000.00 |
| Sep 30, 2021 | 406,000.00 |